Influence of hypodermic needle dimensions on subcutaneous injection delivery--a pig study of injection deposition evaluated by CT scanning, histology, and backflow
- PMID: 22233448
- DOI: 10.1111/j.1600-0846.2011.00592.x
Influence of hypodermic needle dimensions on subcutaneous injection delivery--a pig study of injection deposition evaluated by CT scanning, histology, and backflow
Abstract
Background: Thinner and shorter needles for subcutaneous administration are continuously developed. Previous studies have shown that a thinner needle causes fewer occurrences of painful needle insertions and that a shorter needle decreases the occurrence of painful intramuscular injections. However, little is known about local drug delivery in relation to needle length and thickness. This study aimed to compare deposition depth and backflow from three hypodermic needles of 3 mm 34G (0.19 mm), 5 mm 32G (0.23 mm), and 8 mm 30G (0.30 mm) in length and thickness.
Methods: Ex vivo experiments were carried out on pigs, in neck tissue comparable to human skin at typical injection sites. Six pigs were included and a total of 72 randomized injections were given, i.e. 24 subcutaneous injections given with each needle type. Accordingly, 400 μL was injected including 70% NovoRapid(®) (Novo Nordisk A/S, Bagsvμrd, Denmark) and 30% Xenetix(®) (Guerbet, Villepinte, France) contrast including 1 mg/mL Alcian blue. Surgical biopsies of injection sites were sampled and computer topographic (CT)-scanned in 3D to assess deposition and local distribution. Biopsies were prepared and stained to evaluate deposition in comparison to the CT-scanning findings. The backflow of each injection was collected with filter paper. The blue stains of filter paper were digitized and volume estimated by software calculation vs. control staining.
Results: CT-scanning (n = 57) and histology (n = 10) showed that, regardless of injection depth, the bulk of the injection was in the subcutaneous tissue and did not propagate from subcutis into dermis. With the 8 mm 30G needle all injections apart from one intramuscular injection were located in the subcutaneous layer. The volume depositions peaked in 4-5 mm depth for the 3 mm 34G needle, in 5-6 mm depth for the 5 mm 32G needle, and in 9-10 mm depth for the 8 mm 30G needle. In general, injection depositions evaluated by histology and CT-scans compared well for the individual biopsies. The amount of backflow (n = 69) from the 3 mm 34G needle was smaller (P < 0.05) as compared to the 5 mm 32G and the 8 mm 30G needles. Analysis showed a correlation between backflow and the needle's outer dimension with the needle diameter being the pivotal parameter. Furthermore, CT-scanning and histology confirmed that local propagation of the injection and final distribution followed a route of less mechanical resistance as determined by connective tissue barriers preset in the site of injection.
Conclusion: Needles as short as 3 mm efficiently delivered injections into the subcutaneous target. The amount of backflow was smaller with thinner needles. Local distribution was variable and determined by mechanical barriers preset in the tissue. CT-scans and histology were concordant.
© 2012 John Wiley & Sons A/S.
Similar articles
-
Characterization of needle-assisted jet injections.J Control Release. 2016 Dec 10;243:195-203. doi: 10.1016/j.jconrel.2016.10.010. Epub 2016 Oct 13. J Control Release. 2016. PMID: 27746273
-
Pain following controlled cutaneous insertion of needles with different diameters.Somatosens Mot Res. 2006 Mar-Jun;23(1-2):37-43. doi: 10.1080/08990220600700925. Somatosens Mot Res. 2006. PMID: 16846958 Clinical Trial.
-
Spatial distribution of soluble insulin in pig subcutaneous tissue: Effect of needle length, injection speed and injected volume.Eur J Pharm Sci. 2015 Nov 15;79:96-101. doi: 10.1016/j.ejps.2015.08.012. Epub 2015 Sep 2. Eur J Pharm Sci. 2015. PMID: 26341408
-
Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics.Eur J Pharm Biopharm. 2024 Nov;204:114517. doi: 10.1016/j.ejpb.2024.114517. Epub 2024 Sep 28. Eur J Pharm Biopharm. 2024. PMID: 39349073 Review.
-
Insulin administration: selecting the appropriate needle and individualizing the injection technique.Expert Opin Drug Deliv. 2011 Oct;8(10):1395-406. doi: 10.1517/17425247.2011.614229. Epub 2011 Aug 25. Expert Opin Drug Deliv. 2011. PMID: 21864222 Review.
Cited by
-
The Needle Shield Size and Applied Force of Subcutaneous Autoinjectors Significantly Influence the Injection Depth.J Diabetes Sci Technol. 2025 Sep;19(5):1317-1325. doi: 10.1177/19322968241231996. Epub 2024 Feb 22. J Diabetes Sci Technol. 2025. PMID: 38388411 Free PMC article.
-
Backflow reduction in local injection therapy with gelatin formulations.Drug Deliv. 2024 Dec;31(1):2329100. doi: 10.1080/10717544.2024.2329100. Epub 2024 Mar 22. Drug Deliv. 2024. PMID: 38515401 Free PMC article.
-
Characterization of large volume subcutaneous injections using computed tomography imaging and simultaneous pressure measurements.Front Drug Deliv. 2023 Jul 13;3:1223177. doi: 10.3389/fddev.2023.1223177. eCollection 2023. Front Drug Deliv. 2023. PMID: 40838048 Free PMC article.
-
Injection device-related risk management toward safe administration of medications: experience in a university teaching hospital in The People's Republic of China.Ther Clin Risk Manag. 2014 Mar 17;10:165-72. doi: 10.2147/TCRM.S59199. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 24669192 Free PMC article.
-
Injection Technique and Pen Needle Design Affect Leakage From Skin After Subcutaneous Injections.J Diabetes Sci Technol. 2016 Jun 28;10(4):914-22. doi: 10.1177/1932296815626723. Print 2016 Jul. J Diabetes Sci Technol. 2016. PMID: 26798083 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical